Who
Martha Morrell
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Neuropace.
In numbers
- Trades disclosed
- 101
- Buys
- 0
- Sells
- 16
- Bought
- $0
- Sold
- $2.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 4 Jun 2021
- Last trade
- 24 Sep 2026
- Last filed
- 25 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Sep 2026filed 25 Sep 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $4,680335 at $13.97 | filing |
| 24 Sep 2026filed 25 Sep 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $4,680335 at $13.97 | filing |
| 27 Aug 2026filed 28 Aug 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $5,059358 at $14.13 | filing |
| 27 Aug 2026filed 28 Aug 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $5,059358 at $14.13 | filing |
| 24 Jun 2026filed 25 Jun 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $5,434335 at $16.22 | filing |
| 24 Jun 2026filed 25 Jun 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $5,434335 at $16.22 | filing |
| 27 May 2026filed 28 May 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $6,107358 at $17.06 | filing |
| 27 May 2026filed 28 May 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $6,107358 at $17.06 | filing |
| 15 May 2026filed 19 May 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | —5,460 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —14,550 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —14,550 at $0.00 | filing |
| 15 May 2026filed 19 May 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | —5,460 at $0.00 | filing |
| 24 Mar 2026filed 25 Mar 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $18K1,341 at $13.27 | filing |
| 24 Mar 2026filed 25 Mar 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $18K1,341 at $13.27 | filing |
| 3 Mar 2026filed 4 Mar 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $19K1,340 at $13.83 | filing |
| 3 Mar 2026filed 4 Mar 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $19K1,340 at $13.83 | filing |
| 27 Feb 2026filed 2 Mar 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $5,220358 at $14.58 | filing |
| 27 Feb 2026filed 2 Mar 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $5,220358 at $14.58 | filing |
| 20 Feb 2026filed 23 Feb 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $49K3,412 at $14.34 | filing |
| 20 Feb 2026filed 23 Feb 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code F | $49K3,412 at $14.34 | filing |
News
No headline names them, or the companies they trade most, lately.